Member Resources

Industry intelligence by CLSA keeps members informed of industry trends, political activities affecting industry, best practices for startups, workforce reports and more.  CLSA is committed to providing analysis on the sector’s most important topics.

 

November 16, 2016
2017 California Life Sciences Industry Report
California Life Sciences Association (CLSA) and PwC US issue new report indicating that California’s life sciences industry has 1,269 new medicines in the development pipeline, and in 2015, employed more than 287,000 people, brought in $148 billion in total revenue, paid over $116,000 in average wages, attracted $4.4 billion in venture capital investment and more.»
November 16, 2016
Infographic: Leading the World in Life Sciences Innovation
See the highlights from our 2017 California Life Sciences Industry Report. California leads the world in life sciences innovation. Premier research institutions combine with a unique entrepreneurial spirit to develop new technologies, attract investors and push the state’s economy to greater heights.»
October 3, 2016
CLSA Report: How We Prepare for the Next Pandemic
As deadly pathogens continue to emerge, what can the world do to combat them? Recently, the California Life Sciences Association hosted an Afternoon with Thought Leaders to discuss these issues. »
March 29, 2016
CLSA Report: Tracking FDA Drug Review Performance
Check out this California Life Science Association (CLSA) and Boston Consulting Group report that details trending data about the FDA’s drug review performance. The infographic report shows that the FDA has accelerated review times, descending from an average of 21 months in 2009 to 10 months in 2015, and highlights key areas for improvement moving forward. »
November 24, 2015
2016 California Life Sciences Industry Report
CLSA’s 2016 California Life Sciences Industry Report highlights economic and therapeutic impact trends regarding California’s life sciences innovation ecosystem. The report indicates that the sector has a profound impact on the state’s economy, showing industry increases in the areas of sector employment growth, wages, research funding and life sciences VC investment.

HEALTHY FUTURE FUND DONORS!

CLSA extends its appreciation to the esteemed donors of CLSA’s Healthy Future Fund

Amgen

Biomarin

Cepheus Biosciences

CymaBay

Edwards

Voisin Consulting

Genentech

Genentech

Genomic Health

Genentech

Nektar

OncoMed

Prosetta Biosciences

Riboscience LLC

Voisin Consulting

VWR We Enable Science

*The Healthy Future Fund is comprised of generous member donations to ensure CLSA’s long term success and industrywide impact following its 2015 merger of CHI and BayBio.

MENU